Put Options

9 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2023

May 15, 2023

BUY
$4.92 - $8.21 $607,128 - $1.01 Million
123,400 Added 411.33%
153,400 $757,000
Q4 2022

Feb 14, 2023

BUY
$5.62 - $11.11 $168,600 - $333,300
30,000 New
30,000 $188,000
Q3 2021

Nov 12, 2021

SELL
$21.01 - $27.64 $630,300 - $829,200
-30,000 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$25.79 - $39.02 $773,700 - $1.17 Million
30,000 New
30,000 $1.06 Million
Q3 2020

Nov 16, 2020

SELL
$32.38 - $44.96 $1.3 Million - $1.8 Million
-40,000 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$18.39 - $54.04 $229,875 - $675,500
12,500 Added 45.45%
40,000 $1.71 Million
Q1 2020

May 15, 2020

SELL
$18.22 - $28.25 $45,550 - $70,625
-2,500 Reduced 8.33%
27,500 $535,000
Q4 2019

Feb 13, 2020

BUY
$24.82 - $31.4 $409,530 - $518,100
16,500 Added 122.22%
30,000 $780,000
Q3 2019

Nov 14, 2019

BUY
$26.11 - $32.99 $352,485 - $445,365
13,500 New
13,500 $369,000

Others Institutions Holding ALLO

About Allogene Therapeutics, Inc.


  • Ticker ALLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 143,807,008
  • Market Cap $243M
  • Description
  • Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...
More about ALLO
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.